Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Juliana Alvarez Argote MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Benign Hematology

Member of the Cancer Center


Publications (15)

  • Severe terminal ileitis induced by single-agent nivolumab administered every four weeks. (Dasanu CA, Plaxe SC, Gupta V, Popescu IM, Grover M, Alvarez-Argote J) J Oncol Pharm Pract 2020 Sep;26(6):1516-1519 PMID: 32028838 SCOPUS ID: 2-s2.0-85079465900 02/08/2020    
  • Durvalumab in cancer medicine: a comprehensive review. (Alvarez-Argote J, Dasanu CA) Expert Opin Biol Ther 2019 09;19(9):927-935 PMID: 31272242 SCOPUS ID: 2-s2.0-85070812050 07/06/2019       3 Citations
  • Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs. (Dasanu CA, Alvarez-Argote J, Limonadi FM, Codreanu I) Expert Opin Biol Ther 2019 02;19(2):99-104 PMID: 30556741 SCOPUS ID: 2-s2.0-85060297670 12/18/2018       2 Citations
  • Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents? (Dasanu CA, Samara Y, Codreanu I, Limonadi FM, Hamid O, Alvarez-Argote J) J Oncol Pharm Pract 2019 Apr;25(3):638-647 PMID: 30253729 SCOPUS ID: 2-s2.0-85059350839 09/27/2018       4 Citations
  • Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. (Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC) J Oncol Pharm Pract 2018 04;24(3):229-231 PMID: 28436313 04/25/2017       1 Citation
  • ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival. (Alvarez Argote J, Dasanu CA) Curr Med Res Opin 2018 05;34(5):757-763 PMID: 28027687 SCOPUS ID: 2-s2.0-85045643814 12/29/2016       6 Citations
  • Cancer-related microangiopathic hemolytic anemia. (Choy B, Alvarez Argote J, Treml A) Transfusion 2016 08;56(8):1937 PMID: 27500918 SCOPUS ID: 2-s2.0-84982995109 08/09/2016       1 Citation
  • Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. (Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA) BBA Clin 2016 Dec;6:12-8 PMID: 27331023 PMCID: PMC4900299 06/23/2016    
  • Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. (Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA) Conn Med 2015 Aug;79(7):401-4 PMID: 26411176 09/29/2015    
  • Autoimmune disorders in patients with T-cell lymphoma: a comprehensive review. (Van den Bergh M, Alvarez-Argote J, Panwala AH, Dasanu CA) Curr Med Res Opin 2015;31(10):1861-70 PMID: 26211818 SCOPUS ID: 2-s2.0-84942296898 07/28/2015       7 Citations
  • Autoimmune disorders in patients with hairy cell leukemia: are they more common than previously thought? (Dasanu CA, Van den Bergh M, Pepito D, Alvarez Argote J) Curr Med Res Opin 2015 Jan;31(1):17-23 PMID: 25265129 09/30/2014       8 Citations
  • Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab! (Alvarez Argote J, Bauer FA, Posteraro AF 3rd, Dasanu CA) J Oncol Pharm Pract 2016 Feb;22(1):179-85 PMID: 25013186 07/12/2014       1 Citation
  • CD5 negative mantle cell lymphoma: a different clinical entity? (Alvarez-Argote J, Bauer FA, Dasanu CA) Conn Med 2014 Apr;78(4):211-4 PMID: 24830117 SCOPUS ID: 2-s2.0-84901467611 05/17/2014       2 Citations
  • Decision boxes for clinicians to support evidence-based practice and shared decision making: the user experience. (Giguere A, Légaré F, Grad R, Pluye P, Haynes RB, Cauchon M, Rousseau F, Alvarez Argote J, Labrecque M) Implement Sci 2012 Aug 03;7:72 PMID: 22862935 PMCID: PMC3533695 08/07/2012       30 Citations
  • Survival to leukemia and lymphomas in children at a University Hospital in Cali, Colombia. (Diaz YV, Nichols-Vinueza DX, Alvarez-Argote J, Gutiérrez-Montealegre A, García LE, Bravo LE) J Pediatr Hematol Oncol 2011 Oct;33(7):e284-8 PMID: 21646918 SCOPUS ID: 2-s2.0-80053304694 06/08/2011    
  • Last update: 04/09/2020
    jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a